Caileigh Dougherty
No más puestos en curso
Perfil
Caileigh Dougherty worked as Director-Investor Relations at Athenex, Inc. and as Head-Investor Relations at Intercept Pharmaceuticals, Inc.
Antiguos cargos conocidos de Caileigh Dougherty.
| Empresas | Cargo | Fin |
|---|---|---|
| ATHENEXPAR | Public Communications Contact | 01/09/2022 |
| INTERCEPT PHARMACEUTICALS, INC. | Public Communications Contact | 01/08/2021 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Athenex, Inc.
 Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Caileigh Dougherty
